Terms: = Ovarian germ cell tumor AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
27 results:
1. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.
Galpin KJC; Rodriguez GM; Maranda V; Cook DP; Macdonald E; Murshed H; Zhao S; McCloskey CW; Chruscinski A; Levy GA; Ardolino M; Vanderhyden BC
Sci Rep; 2024 Jan; 14(1):787. PubMed ID: 38191799
[TBL] [Abstract] [Full Text] [Related]
2. Immunity and reproduction protective effects of Chitosan Oligosaccharides in Cyclophosphamide/Busulfan-induced premature ovarian failure model mice.
Li X; Ye H; Su T; Hu C; Huang Y; Fu X; Zhong Z; Du X; Zheng Y
Front Immunol; 2023; 14():1185921. PubMed ID: 37228612
[TBL] [Abstract] [Full Text] [Related]
3. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
[TBL] [Abstract] [Full Text] [Related]
4. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
5. TTDA inhibited apoptosis by regulating the p53-Bax/Bcl2 axis in glioma.
Bai HL; Kang CM; Sun ZQ; Li XH; Dai XY; Huang RY; Zhao JJ; Bei YR; Huang XZ; Lu ZF; Wu SG; Lu JB; Ping BH; Wang Q; Hu YW
Exp Neurol; 2020 Sep; 331():113380. PubMed ID: 32540359
[TBL] [Abstract] [Full Text] [Related]
6. Routine Plasma-Based Genotyping to Comprehensively Detect germline, Somatic, and Reversion
Vidula N; Rich TA; Sartor O; Yen J; Hardin A; Nance T; Lilly MB; Nezami MA; Patel SP; Carneiro BA; Fan AC; Brufsky AM; Parker BA; Bridges BB; Agarwal N; Maughan BL; Raymond VM; Fairclough SR; Lanman RB; Bardia A; Cristofanilli M
Clin Cancer Res; 2020 Jun; 26(11):2546-2555. PubMed ID: 32034076
[TBL] [Abstract] [Full Text] [Related]
7. Tetra-cationic platinum(II) porphyrins like a candidate photosensitizers to bind, selective and drug delivery for metastatic melanoma.
Couto GK; Pacheco BS; Borba VM; Junior JCR; Oliveira TL; Segatto NV; Seixas FK; Acunha TV; Iglesias BA; Collares T
J Photochem Photobiol B; 2020 Jan; 202():111725. PubMed ID: 31790880
[TBL] [Abstract] [Full Text] [Related]
8. Prophylactic
Li C; Course MM; McNeish IA; Drescher CW; Valdmanis PN; Lieber A
Cancer Res; 2020 Feb; 80(3):549-560. PubMed ID: 31727629
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
Slavin TP; Coffee B; Bernhisel R; Logan J; Cox HC; Marcucci G; Weitzel J; Neuhausen SL; Mancini-DiNardo D
Cancer Genet; 2019 Jun; 235-236():31-38. PubMed ID: 31056428
[TBL] [Abstract] [Full Text] [Related]
10. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
[TBL] [Abstract] [Full Text] [Related]
11. Chemosensitivity of BRCA1-Mutated ovarian Cancer cells and Established Cytotoxic Agents.
van Haaften C; van Eendenburg J; Boot A; Corver WE; Haans L; van Wezel T; Trimbos JB
Int J Gynecol Cancer; 2017 Oct; 27(8):1571-1578. PubMed ID: 28604461
[TBL] [Abstract] [Full Text] [Related]
12. Reversion of BRCA1/2 germline Mutations Detected in Circulating tumor DNA From Patients With High-Grade Serous ovarian Cancer.
Christie EL; Fereday S; Doig K; Pattnaik S; Dawson SJ; Bowtell DDL
J Clin Oncol; 2017 Apr; 35(12):1274-1280. PubMed ID: 28414925
[TBL] [Abstract] [Full Text] [Related]
13. [Placental site trophoblastic tumor: When do we suspect it and which treatment shall we decide?].
Nguyen Ba E; Golfier F; Malhaire C; Louafi L; Alran S
J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):979-984. PubMed ID: 27692520
[TBL] [Abstract] [Full Text] [Related]
14. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected].
Khan I; Zakaria MK; Kumar M; Mani P; Chattopadhyay P; Sarkar DP; Sinha S
J Transl Med; 2015 Aug; 13():254. PubMed ID: 26242403
[TBL] [Abstract] [Full Text] [Related]
15. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract] [Full Text] [Related]
16. SKOV-3 and Me45 cell response to cisplatin-based chemotherapy: an in vitro study.
Gonera A; Wawryka J; Sobkowicz A; Biezunska-Kusiak K; Dubinska-Magiera M; Krajewski A; Choromanska A
Folia Biol (Praha); 2014; 60(5):213-9. PubMed ID: 25863038
[TBL] [Abstract] [Full Text] [Related]
17. VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.
Ghosh S; Maity P
J Environ Pathol Toxicol Oncol; 2010; 29(1):17-30. PubMed ID: 20528744
[TBL] [Abstract] [Full Text] [Related]
18. Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma.
Archer CR; Koomoa DL; Mitsunaga EM; Clerc J; Shimizu M; Kaiser M; Schellenberg B; Dudler R; Bachmann AS
Biochem Pharmacol; 2010 Jul; 80(2):170-8. PubMed ID: 20362557
[TBL] [Abstract] [Full Text] [Related]
19. Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation.
Wang Y; Zhang Z; Lu Y; Yao R; Jia D; Wen W; LaRegina M; Crist K; Lubet R; You M
Mol Cancer Res; 2008 Jan; 6(1):99-109. PubMed ID: 18234966
[TBL] [Abstract] [Full Text] [Related]
20. Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis.
Coleman CS; Rocetes JP; Park DJ; Wallick CJ; Warn-Cramer BJ; Michel K; Dudler R; Bachmann AS
Cell Prolif; 2006 Dec; 39(6):599-609. PubMed ID: 17109642
[TBL] [Abstract] [Full Text] [Related]
[Next]
